Atherosclerosis and Oxidant Stress: A New Perspective

Atherosclerosis and Oxidant Stress: A New Perspective

von: Jordan L Holtzman

Springer-Verlag, 2007

ISBN: 9780387723471 , 247 Seiten

Format: PDF, OL

Kopierschutz: Wasserzeichen

Windows PC,Mac OSX für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's Online-Lesen für: Windows PC,Mac OSX,Linux

Preis: 96,29 EUR

  • Urodynamik
    Medical Retina
    Color Doppler US of the Penis
    Leistungsphysiologie - Grundlagen für Trainer, Physiotherapeuten und Masseure
    Musculoskeletal Sonography - Technique, Anatomy, Semeiotics and Pathological Findings in Rheumatic Diseases
    Oncology - An Evidence-Based Approach
  • Glaucoma
    Glaukom 2007 - Die Papille beim Glaukom
    Telesurgery
    Dental Pathology - A Practical Introduction
    Drugs Compromising Male Sexual Health
    Oral Pharmacotherapy for Male Sexual Dysfunction - A Guide to Clinical Management
 

Mehr zum Inhalt

Atherosclerosis and Oxidant Stress: A New Perspective


 

Preface

5

Contents

6

Contributors

8

The Pathogenesis of Atherosclerosis and Plaque Instability

10

Creation of the Lipid Core

11

Local Inflammation in the Vessel Wall

13

Thinning of the Fibrous Cap

14

References

16

Epidemiological Studies on Atherosclerosis: The Role of the Mediterranean Diet in the Prevention of Cardiovascular Disease

20

Introduction

20

The Mediterranean Diet and Risk of CVD

21

Observational Study Results

21

Clinical Trial Results – Variations to the Mediterranean Diet

25

The Lyon Diet Heart Study

25

Indo-Mediterranean Diet Heart Study

26

Clinical Feeding Study Results

27

The Dash Trials

27

OMNI Heart Trial

28

Mediterranean Diet Effects on Oxidative Stress

29

Summary and Conclusion

31

References

32

Interventional Trials of Antioxidants

34

Introduction

34

Basic Laboratory Research

34

Observational Epidemiology

35

Rationale for Randomized Trials

37

Vitamin E Primary Prevention Trials

37

Vitamin E Secondary Prevention Trials

40

Beta-carotene Primary Prevention Trials

44

Beta-carotene Secondary Prevention Trials

47

Vitamin C Trials

49

Combination Antioxidant Primary Prevention Trials

49

Combination Antioxidant Secondary Prevention Trials

51

Conclusions

54

Recommendations

55

References

55

Oxidative stress and Hypertension

60

Introduction

60

The Paradigm of Oxidative Stress: Reduction– Oxidation Concepts

61

Vascular Production of Reactive Oxygen Species

63

Vascular NAD(P)H Oxidases

63

Uncoupling of NOS

66

Vascular Antioxidant Defense Systems

67

Molecular Targets of Reactive Oxygen Species in Vascular Cells

67

Transcription Factors

68

Protein Tyrosine Phosphatases

69

Protein Tyrosine Kinases (PTK)

69

Mitogen-Activated Protein Kinases

70

Cation Transport Systems

70

Vascular Mechanisms of Oxidative Stress in Hypertension

71

Reactive Oxygen Species Influence Vascular Structure and are Pro-inflammatory

71

Reactive Oxygen Species Reduce NO Bioavailability

71

Reactive Oxygen Species in Hypertension

72

Oxidative Stress in Experimental Models of Hypertension

72

Oxidative Stress in Human Hypertension

73

Therapeutic Potential of Altering Bioavailability of Reactive Oxygen Species

73

Conclusions

77

References

78

Lipids, Oxidation, and Cardiovascular Disease

88

The Impact of Cardiovascular Disease and Its Major Component, Coronary Heart Disease on Human Health

88

Blood Lipids and Coronary Heart Disease

89

The Influence of Dietary Fats on Blood Cholesterol Levels and Distribution of Fatty Acids

90

The Pathogenesis of Coronary Heart Disease

92

Oxidized Lipids and Atherosclerosis

94

Mitochondria, Oxidative Stress, and Bioactive Lipids: A New Concept

96

Controlled Release of Reactive Oxygen Species for Mitochondria and Cellular Redox Signaling Pathways

97

Pathways Influenced by Mitochondrial ROS and Oxidized Lipids

98

Oxidized LDL, Signal Transduction Pathways, and Protection of Vascular Cells

98

Summary

99

References

100

Nuclear Receptors in the Control of Lipid Metabolism

105

The Nuclear Receptor Superfamily

105

Class I Receptors – the Classic Nuclear Hormone Receptors

107

Class II – the Metabolic Sensors

109

Class III and Class IV – the Orphans

117

Nuclear Receptors as Potential Therapeutic Targets for Metabolic Diseases

118

Conclusion

120

References

120

Diabetes and Oxidant Stress

132

Definition and Prevalence of Diabetes

134

Chronic Complications of Diabetes and Risk Factors

134

Definition and Mechanisms of Oxidative Stress

136

Measurement of Oxidative Stress

137

Is Oxidative Stress per se Increased in Diabetes and Vascular Damage?

139

The Link Between Oxidative Stress and Vascular Damage in Diabetes

149

Treatment of Oxidative Stress

150

Conclusion and Future Directions

153

References

154

Molecular Mechanisms of Environmental Atherogenesis

168

Epidemiology of Cardiovascular Disease

168

Atherosclerosis

169

Response to Injury Hypothesis

169

Clonal Expansion Hypothesis

171

Pathogenesis of Atherosclerosis

172

Environmental Risk Factors

173

Atherogens vs. Carcinogens

176

Reactive Oxygen Species and Oxidative Stress

177

Cellular Redox Reactions

178

Redox Cycling

178

Reactive Oxygen Species and Atherosclerosis

179

Reactive Oxygen Species as Second Messengers

180

Reactive Oxygen Species as Protein Modifiers and Phosphorylation Mediators

181

Benzo[a]pyrene

182

Bay Region Hypothesis

182

Metabolism of Benzo[a]pyrene, Enzyme Systems and Reactivity of Metabolites

183

Target Organs and Cellular Localization of Benzo[a]pyrene

187

Benzo[a]pyrene Carcinogenicity

187

Macromolecular Adduction

189

Benzo[a]pyrene and Atherosclerosis

191

Modulation of Gene Expression by Benzo[a]pyrene through the Aryl Hydrocarbon Receptor

192

c-Ha-ras

194

Signal Transduction through the Ras Pathway

195

c-Ha-ras and Atherosclerosis

197

c-Ha-ras and Benzo[a]pyrene

198

c-Ha-ras and Redox Signaling Pathways

198

Mitogenic Signaling Induced by Benzo[a]pyrene

199

Oxidant-Regulated Signaling in vSMCs

200

Antioxidant/Electrophile Response Element

201

Protein Binding to ARE/EpRE

202

Concluding Remarks

203

References

204

The Role of Glutathione Pathways in the Prevention of Atherosclerosis

220

The Role of Oxidized Serum Lipids in the Chronic Vascular Inflamation Associated with the Development of Atherosclerosis

220

Mechanisms for the Initiation of Vessel Injury by Oxidized Lipids

221

The Role of Antioxidant Systems in the Protection of the Vessel Wall from Oxidant Injury

222

The Correlation between the GSH and Cysteine Levels and Vascular Disease

222

The Selenium Dependent GSH-Peroxidases and Paraoxonases

223

The Role of GPx1 in the Prevention of Vascular Injury

224

The Role of GPx3 in the Prevention of Vascular Disease

226

The Role of the Gluthathione S-Transferases Polymorphinsms in the Development of Vascular Disease

229

Effect of Ischemic Heart Disease, Diabetes Mellitus and Chronic Renal Failure on the GSH Peroxidases

232

Ischemic Heart Disease

232

Diabetes Mellitus

232

The Effect of Renal Failure on the Antioxidant Pathways

234

The Effect of Drugs on the GSH Dependent Pathways

234

Hormone Replacement Therapy

234

Statins and Fibrates

235

Conclusions

236

References

236

Index

249